 China Biologic Products Holdings, Inc. NASDAQ: CBPO China Biologic or the Company, a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its fourth quarter and fiscal year 2019 financial results on Thursday, March 12, 2020 after the market closes. 